-
1.发明申请公开(公告)号：US20220098325A1
公开(公告)日：2022-03-31
申请号：US17473401
申请日：2021-09-13
Applicant: Genentech, Inc.
Inventor： Teemu T. JUNTTILA , Stuart LUTZKER
IPC: C07K16/32 , A61P35/00 , C07K16/28 , A61K45/06 , A61K39/395
Abstract: The present invention provides methods of treating of HER2-positive cancers (such as HER2-positive breast cancer and HER2-positive gastric cancers) using HER2 antibodies, such as a combination of a HER2 T cell-dependent bispecific antibody (TDB) with an additional HER2 antibody (e.g., trastuzumab).
Search Results
1
records
(took 0.01 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
